Steven M. Fruchtman

This profile gathers the share dealings of Steven M. Fruchtman in Traws Pharma, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 28 September 2021 to 13 March 2024, the count stands at 6 filings.

The open-market record is one-sided, with 1 purchase worth €8,557 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 option exercises.

The record was last updated on 15 March 2024 with an option exercise in Traws Pharma, Inc. The latest purchase dates back some time: it was published 1,846 days ago, on 28 September 2021. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.